Bruker Daltonics GmbH & Co. KG - Bruker Microbiology & Infection Diagnostics – Changing Microbiology

White Paper

Enhance clinical microbiology through mass spectrometry

November 7, 2022

In an era where bacteria, parasites and fungi are becoming increasingly resistant to antibiotics, the ability to tailor these drugs quickly and precisely is growing in importance. Dr Alexia Verroken, assistant laboratory leader at Saint-Luc University Clinic, tells Practical Patient Care about how using Bruker Daltonics’ mass spectrometry technology can enhance clinical microbiology operations.

Download to find out more.